[go: up one dir, main page]

AU2001270310A1 - Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same - Google Patents

Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same

Info

Publication number
AU2001270310A1
AU2001270310A1 AU2001270310A AU7031001A AU2001270310A1 AU 2001270310 A1 AU2001270310 A1 AU 2001270310A1 AU 2001270310 A AU2001270310 A AU 2001270310A AU 7031001 A AU7031001 A AU 7031001A AU 2001270310 A1 AU2001270310 A1 AU 2001270310A1
Authority
AU
Australia
Prior art keywords
taxanes
antineoplastic
compositions
making
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001270310A
Inventor
Wenbin Dang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Corp of North America
Original Assignee
Guilford Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Guilford Pharmaceuticals Inc filed Critical Guilford Pharmaceuticals Inc
Publication of AU2001270310A1 publication Critical patent/AU2001270310A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2001270310A 2000-07-07 2001-07-09 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same Abandoned AU2001270310A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US21687400P 2000-07-07 2000-07-07
US60/216,874 2000-07-07
US23979800P 2000-10-12 2000-10-12
US60/239,798 2000-10-12
PCT/US2001/021594 WO2002003957A2 (en) 2000-07-07 2001-07-09 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same

Publications (1)

Publication Number Publication Date
AU2001270310A1 true AU2001270310A1 (en) 2002-01-21

Family

ID=26911410

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001270310A Abandoned AU2001270310A1 (en) 2000-07-07 2001-07-09 Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same

Country Status (3)

Country Link
US (1) US20020041897A1 (en)
AU (1) AU2001270310A1 (en)
WO (1) WO2002003957A2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6537585B1 (en) 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors
US20020141966A1 (en) * 2000-11-16 2002-10-03 Wenbin Dang Compositions for treatment of malignant effusions, and methods of making and using the same
US8097433B2 (en) * 2005-11-22 2012-01-17 Common Sense, Ltd. Diagnostic composition and article for monitoring intravaginal infections
US20050238616A1 (en) * 2002-01-09 2005-10-27 Guilford Pharmaceuticals, Inc. Compositions for treatment of central nervous system neoplasms, and methods of making and using the same
AU2003304108B2 (en) * 2002-10-30 2007-03-22 Spherics, Inc. Nanoparticulate bioactive agents
AU2005251691A1 (en) * 2004-05-17 2005-12-22 Tekmira Pharmaceuticals Corporation Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
EP3659589A1 (en) 2005-08-31 2020-06-03 Abraxis BioScience, LLC Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
KR101643416B1 (en) * 2005-08-31 2016-07-27 아브락시스 바이오사이언스, 엘엘씨 Compositions and methods for preparation of poorly water soluble drugs with increased stability
CN105277656B (en) 2014-07-01 2018-12-25 科蒙森斯公司 Diagnostic composition for identifying amniotic fluid

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA54505C2 (en) * 1997-04-03 2003-03-17 Гілфорд Фармасьютікалз Інк. Biodegradable polymers, bound by phosphates, compositions, products and pocesses for manufacturing and using thereof
WO1998048859A1 (en) * 1997-04-30 1998-11-05 Guilford Pharmaceuticals Inc. Biodegradable compositions comprising poly(cycloaliphatic phosphoester) compounds, articles, and methods for using the same
US6350464B1 (en) * 1999-01-11 2002-02-26 Guilford Pharmaceuticals, Inc. Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same
US6537585B1 (en) * 1999-03-26 2003-03-25 Guilford Pharmaceuticals, Inc. Methods and compositions for treating solid tumors

Also Published As

Publication number Publication date
WO2002003957A3 (en) 2003-03-13
US20020041897A1 (en) 2002-04-11
WO2002003957A2 (en) 2002-01-17

Similar Documents

Publication Publication Date Title
AU2001280597A1 (en) Compositions for sustained release of analgesic agents, and methods of making and using the same
AU2001276048A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001279284A1 (en) Rapid-melt semi-solid compositions, methods of making same and methods of using same
AU2001258359A1 (en) Ir-absorbing compositions
AU2001280604A1 (en) Compositions comprising icariside i and anhydroicaritin and methods for making the same
AU2002357119A1 (en) Mitocidal compositions and methods
AU2001264264A1 (en) Sustained release compositions
AU2002357748A1 (en) Osteopontin-related compositions and methods
AU2002215333A1 (en) Compositions for release of radiosensitizers, and methods of making and using the same
AU2001241098A1 (en) Composition
AU2001270310A1 (en) Compositions for sustained release of antineoplastic taxanes, and methods of making and using the same
AU2001264109A1 (en) Parasiticidal composition
AU3883800A (en) Hob-bp2h compositions, methods and uses thereof
AU2001275201A1 (en) Acne-treating composition
AU2002229654A1 (en) Nanoparticle-containing peeling compositions
AU2001287852A1 (en) Composition
AU2001235764A1 (en) Compositions
AU2001252671A1 (en) Pyridobenzodiazine derivatives and processes for the preparation thereof
AU2000261768A1 (en) An improved process for the preparation of docetaxel
AU2001267541A1 (en) Vaccine composition
AU2001232089A1 (en) Compound, composition and use
AU2001232080A1 (en) Compound, compositions and use
AU2001287732A1 (en) Copolycarbonate-based composition
AU2001262163A1 (en) Composition
AU2001211674A1 (en) Naphthomelanins, process for their preparation and compositions thereof